Pharmally mess won’t lead to Duterte – PalaceMANILA, Philippines — The Senate inquiry has yet to prove claims of overpricing in the purchase of COVID-19 supplies last year from Pharmally Pharmaceutical Corp. and Malacañang is confident that the probe won’t lead to President Duterte. “The first issue they threw at Pharmally was overpricing. Did they find overpriced face shields, PPE (personal protective equipment)? The COA (Commission on Audit) has already said that there is nothing overpriced, so what can be linked to the President? Pharmally, linked to Duterte’s former economic adviser Michael Yang, was awarded by the government pandemic supply contracts amounting to P8.68 billion last year.

Source: Philippine Star September 27, 2021 16:00 UTC